Brain scan breakthrough could personalize cancer treatment
NCT ID NCT03297125
Summary
This study aims to determine if advanced MRI scans can predict which patients with newly diagnosed glioblastoma (an aggressive brain cancer) will respond best to Optune therapy. Researchers will compare standard and advanced MRI images from 60 patients receiving Optune plus chemotherapy to see which scan type better forecasts treatment success. The goal is to find a reliable way to identify patients most likely to benefit from this therapy, potentially improving treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Froedtert Hospital & Medical College of Wisconsin
Milwaukee, Wisconsin, 53202, United States
Conditions
Explore the condition pages connected to this study.